Mifepristone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00834 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | punctate epithelial keratoconjunctivitis | KG + DL |
| 2 | rosacea | KG + DL |
| 3 | otitis externa | KG + DL |
| 4 | post-bacterial disorder | KG + DL |
| 5 | postinfectious vasculitis | KG + DL |
| 6 | infective urethral stricture | KG + DL |
| 7 | post-infectious syndrome | KG + DL |
| 8 | Chagas cardiomyopathy | KG + DL |
| 9 | infection-related hemolytic uremic syndrome | KG + DL |
| 10 | parasitic eyelid infestation | KG + DL |
| 11 | ulcerative blepharitis | KG + DL |
| 12 | acne (disease) | KG + DL |
| 13 | noninfectious dermatoses of eyelid | KG + DL |
| 14 | blepharoconjunctivitis | KG + DL |
| 15 | lichen disease | KG + DL |
| 16 | exposure keratitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.